This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1988 Dec;2(8626-8627):1467-9.

doi: 10.1016/s0140-6736(88)90942-7.

Duodenal ulcer, Campylobacter pylori, and the "leaking roof" concept

Affiliations

PMID: 2904580
DOI: 10.1016/s0140-6736(88)90942-7

Review

Duodenal ulcer, Campylobacter pylori, and the "leaking roof" concept

C S Goodwin. Lancet. 1988 Dec.

. 1988 Dec;2(8626-8627):1467-9.

doi: 10.1016/s0140-6736(88)90942-7.

Author

Affiliation

¹ Microbiology Department, Royal Perth Hospital, Western Australia.

PMID: 2904580
DOI: 10.1016/s0140-6736(88)90942-7

No abstract available

PubMed Disclaimer

Similar articles

Bismuth, Campylobacter, and ulcer relapse.
de Wal J. de Wal J. Lancet. 1988 Apr 9;1(8589):824. doi: 10.1016/s0140-6736(88)91683-2. Lancet. 1988. PMID: 2895340 No abstract available.
Pathogenicity of Campylobacter pylori in the upper gastrointestinal tract--implications for modern therapy.
Lambert JR, McLean AJ. Lambert JR, et al. Med J Aust. 1989 Aug 7;151(3):120-2. doi: 10.5694/j.1326-5377.1989.tb139593.x. Med J Aust. 1989. PMID: 2755371 No abstract available.
Cure of duodenal ulcer after eradication of Helicobacter pylori.
George LL, Borody TJ, Andrews P, Devine M, Moore-Jones D, Walton M, Brandl S. George LL, et al. Med J Aust. 1990 Aug 6;153(3):145-9. doi: 10.5694/j.1326-5377.1990.tb136833.x. Med J Aust. 1990. PMID: 1974027
Colloidal bismuth in the treatment of duodenal ulceration: the benefit for the patient.
Miller JP. Miller JP. Scand J Gastroenterol Suppl. 1989;157:16-20; discussion 21-2. doi: 10.3109/00365528909091046. Scand J Gastroenterol Suppl. 1989. PMID: 2568684 Review.
The potential impact of Campylobacter pylori on the treatment of duodenal ulcer disease.
Miller JP, Faragher EB. Miller JP, et al. Scand J Gastroenterol Suppl. 1989;160:39-45. doi: 10.3109/00365528909091734. Scand J Gastroenterol Suppl. 1989. PMID: 2573145 Review.

See all similar articles

Cited by

Helicobacter pylori and duodenal ulcer. Evidence suggesting causation.
Mégraud F, Lamouliatte H. Mégraud F, et al. Dig Dis Sci. 1992 May;37(5):769-72. doi: 10.1007/BF01296437. Dig Dis Sci. 1992. PMID: 1563322 Review. No abstract available.
Helicobacter pylori in gastroduodenal disease.
Loffeld RJ. Loffeld RJ. Pharm Weekbl Sci. 1990 Apr 27;12(2):46-50. doi: 10.1007/BF01970145. Pharm Weekbl Sci. 1990. PMID: 2110652 Review.
Duodenal ulcer, Helicobacter pylori, and gastric secretion.
Chandrakumaran K, Vaira D, Hobsley M. Chandrakumaran K, et al. Gut. 1994 Aug;35(8):1033-6. doi: 10.1136/gut.35.8.1033. Gut. 1994. PMID: 7926901 Free PMC article.
A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection.
Hackelsberger A, Malfertheiner P. Hackelsberger A, et al. Drug Saf. 1996 Jul;15(1):30-52. doi: 10.2165/00002018-199615010-00003. Drug Saf. 1996. PMID: 8862962 Review.
In vitro susceptibility of Helicobacter pylori to the new oral cephalosporins cefpodoxime, ceftibuten and cefixime.
Westblom TU, Gudipati S, Midkiff BR. Westblom TU, et al. Eur J Clin Microbiol Infect Dis. 1990 Sep;9(9):691-3. doi: 10.1007/BF01964274. Eur J Clin Microbiol Infect Dis. 1990. PMID: 2226500

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information